VI was not significantly correlated with all the molecular subtypes of invasive breast cancer, this may be due to that one of the most important limitations in this study was that ER, PR, and HER-2 levels were evaluated using IHC. The gene discussed is PGR; the disease is invasive breast carcinoma.